English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/132676
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Nioplexes encapsulated in supramolecular hybrid biohydrogels as versatile delivery platforms for nucleic acids

AuthorsGrijalvo, Santiago ; Puras, Gustavo; Zárate, Jon; Pons, Ramon; Pedraz, Jose Luis; Eritja Casadellà, Ramón ; Díaz Díaz, David
KeywordsSupramolecular hydrogels
Nioplexes
Supramolecular hybrid biohydrogels
Nucleic acids
Issue Date11-Apr-2016
PublisherRoyal Society of Chemistry
CitationRoyal Society of Chemistry (Great Britain) 46(6): 39688-39699(2016)
AbstractSupramolecular hydrogels based on N-protected phenylalanine (Fmoc–Phe–OH) were used to encapsulate non-ionic surfactant vesicles (niosomes). The niosomes consisted of an amphiphilic lipid mixed with polysorbate-80 and electrostatically complexed with a fluorescently labelled oligodeoxynucleotide (FITC–ODN) as a model nucleic acid derivative. The diffusion properties of the supramolecular hydrogel were conveniently tuned by adding a small amount of κ-carrageenan (≤1% w/v) as a crosslinking agent. Interestingly, neither cationic niosomes nor the biopolymer additive significantly affected the hydrogelation properties of the amino acid-based low molecular weight (LMW) gelator. In vitro drug release experiments from Fmoc–Phe–OH hydrogels containing cationic niosomes were successfully carried out in the absence and in the presence of κ-carrageenan. The niosomal ODN liberation in solution was fitted using Higuchi, Korsmeyer–Peppas and Weibull drug release models, showing the prevalence of diffusion mechanisms in each case. Moreover, the time release was easily prolonged by increasing the concentration of κ-carrageenan. Preliminary transfection studies indicate the suitability of these supramolecular hybrid hydrogels to embed niosomal formulations and, consequently, for being used as tunable delivery vehicles for nucleic acids.
Publisher version (URL)http://dx.doi.org/10.1039/C6RA01005A
URIhttp://hdl.handle.net/10261/132676
DOI10.1039/C6RA01005A
Appears in Collections:(IQAC) Artículos
Files in This Item:
File Description SizeFormat 
RSCAdvances2016.pdf2,95 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.